During the past decade, University Hospital of Ioannina conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 26 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 22 clinical trials were completed. i.e. 44.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of Ioannina" #1 sponsor was "Boehringer Ingelheim" with 14 trials, followed by "University of Ioannina" with 13 trials sponsored, "Hellenic Cooperative Oncology Group" with 11 trials sponsored, "Bayer" with 9 trials sponsored and "Hoffmann-La Roche" with 9 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Ioannina" #1 collaborator was "Sanofi" with 6 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "University of Ioannina" with 2 trials as a collaborator and "1st DIVISION OF INTERNAL MEDICINE, UNIVERSITY GENERAL HOSPITAL OF IOANNINA" with 1 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of Ioannina" are "Multiple Myeloma" (6 trials), "Breast Cancer" (5 trials), "Ulcerative Colitis" (4 trials), "Atrial Fibrillation" (3 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "University Hospital of Ioannina" in a lesser frequency.

Most popular intervention types in "University Hospital of Ioannina" are "Drug" (83 trials), "Other" (12 trials), "Procedure" (11 trials), "Device" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Dexamethasone" (5 trials), "Empagliflozin" (4 trials), "Pomalidomide" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of Ioannina" are 110 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital of Ioannina". 2 are not yet recruiting, 25 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in University Hospital of Ioannina, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of Ioannina, 3 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".